Prospective Clinical Registry of Acute Treatment and Long-term Assessment of Children Meningitis
Launched by HOSPITAL ISRAELITA ALBERT EINSTEIN · Jul 10, 2025
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how children with meningitis—a serious infection of the lining around the brain and spinal cord—are treated and how they recover both during their hospital stay and after they go home. The study will take place in about 20 hospitals across Brazil and will collect information to better understand current treatment methods and long-term outcomes. This will help doctors improve care for children with different types of meningitis, including bacterial, viral, and fungal infections.
Children under 18 who have a fever along with symptoms like severe headache, vomiting, confusion, sensitivity to light, seizures, stiff neck, or a sudden rash may be eligible to join. For babies under two years old, signs such as irritability, constant crying, sleepiness, or a soft spot on the head that looks swollen are also considered. Families who agree to participate will have their child’s health closely followed during the hospital stay and after discharge to see how well treatments are working. The study is not yet enrolling participants but aims to gather important real-world information to help improve care for children with meningitis in Brazil.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Fever (axillary temperature ≥37.8°C) followed by two or more of the following symptoms\*: severe headache, vomiting, altered consciousness (confusion, drowsiness, or irritability), photophobia (increased sensitivity to light), presence of seizures OR
- • Fever accompanied by at least one meningeal irritation sign, such as neck stiffness, Kernig's sign, or Brudzinski's sign OR
- • Sudden onset of fever and appearance of petechial skin rash or hemorrhagic suffusions
- • In children younger than two years, in addition to the presentations listed above, consider fever with any of the following: irritability, persistent crying, somnolence, or bulging fontanelle.
- Exclusion Criteria:
- • Refusal to provide consent for study participation
About Hospital Israelita Albert Einstein
Hospital Israelita Albert Einstein is a leading healthcare institution in Brazil, renowned for its commitment to excellence in patient care, education, and research. As a prominent clinical trial sponsor, the hospital emphasizes innovation and scientific advancement, facilitating cutting-edge studies across various medical disciplines. With a state-of-the-art infrastructure and a dedicated team of professionals, Hospital Israelita Albert Einstein fosters collaboration with global research networks to enhance clinical outcomes and contribute to the advancement of medical knowledge. The institution is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Henrique A Fonseca
Study Chair
Hospital Israelita Albert Einstein
Anna M Gomes
Principal Investigator
Hospital Israelita Albert Einstein
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported